Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

The Ability of Lytic Staphylococcal Podovirus vB_SauP_phiAGO1.3 to Coexist in Equilibrium With Its Host Facilitates the Selection of Host Mutants of Attenuated Virulence but Does Not Preclude the Phage Antistaphylococcal Activity in a Nematode Infection Model.

Głowacka-Rutkowska A, Gozdek A, Empel J, Gawor J, Żuchniewicz K, Kozińska A, Dębski J, Gromadka R, Łobocka M.

Front Microbiol. 2019 Jan 18;9:3227. doi: 10.3389/fmicb.2018.03227. eCollection 2018.

2.

Protein AMPylation by an Evolutionarily Conserved Pseudokinase.

Sreelatha A, Yee SS, Lopez VA, Park BC, Kinch LN, Pilch S, Servage KA, Zhang J, Jiou J, Karasiewicz-Urbańska M, Łobocka M, Grishin NV, Orth K, Kucharczyk R, Pawłowski K, Tomchick DR, Tagliabracci VS.

Cell. 2018 Oct 18;175(3):809-821.e19. doi: 10.1016/j.cell.2018.08.046. Epub 2018 Sep 27.

PMID:
30270044
3.

Phage Therapy: Beyond Antibacterial Action.

Górski A, Jończyk-Matysiak E, Międzybrodzki R, Weber-Dąbrowska B, Łusiak-Szelachowska M, Bagińska N, Borysowski J, Łobocka MB, Węgrzyn A, Węgrzyn G.

Front Med (Lausanne). 2018 May 23;5:146. doi: 10.3389/fmed.2018.00146. eCollection 2018.

4.

Phage Therapy: What Have We Learned?

Górski A, Międzybrodzki R, Łobocka M, Głowacka-Rutkowska A, Bednarek A, Borysowski J, Jończyk-Matysiak E, Łusiak-Szelachowska M, Weber-Dąbrowska B, Bagińska N, Letkiewicz S, Dąbrowska K, Scheres J.

Viruses. 2018 May 28;10(6). pii: E288. doi: 10.3390/v10060288. Review.

5.

Complete Genome Sequences of Two Novel Staphylococcus aureus Podoviruses of Potential Therapeutic Use, vB_SauP_phiAGO1.3 and vB_SauP_phiAGO1.9.

Gozdek A, Głowacka-Rutkowska A, Gawor J, Empel J, Gromadka R, Łobocka MB.

Genome Announc. 2018 Apr 26;6(17). pii: e00048-18. doi: 10.1128/genomeA.00048-18.

6.

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.

Rohde C, Resch G, Pirnay JP, Blasdel BG, Debarbieux L, Gelman D, Górski A, Hazan R, Huys I, Kakabadze E, Łobocka M, Maestri A, Almeida GMF, Makalatia K, Malik DJ, Mašlaňová I, Merabishvili M, Pantucek R, Rose T, Štveráková D, Van Raemdonck H, Verbeken G, Chanishvili N.

Viruses. 2018 Apr 5;10(4). pii: E178. doi: 10.3390/v10040178.

7.

Taxonomy of prokaryotic viruses: 2017 update from the ICTV Bacterial and Archaeal Viruses Subcommittee.

Adriaenssens EM, Wittmann J, Kuhn JH, Turner D, Sullivan MB, Dutilh BE, Jang HB, van Zyl LJ, Klumpp J, Lobocka M, Moreno Switt AI, Rumnieks J, Edwards RA, Uchiyama J, Alfenas-Zerbini P, Petty NK, Kropinski AM, Barylski J, Gillis A, Clokie MRC, Prangishvili D, Lavigne R, Aziz RK, Duffy S, Krupovic M, Poranen MM, Knezevic P, Enault F, Tong Y, Oksanen HM, Rodney Brister J.

Arch Virol. 2018 Apr;163(4):1125-1129. doi: 10.1007/s00705-018-3723-z. Epub 2018 Jan 22. No abstract available.

PMID:
29356990
8.

Methods for Bacteriophage Preservation.

Łobocka MB, Głowacka A, Golec P.

Methods Mol Biol. 2018;1693:219-230. doi: 10.1007/978-1-4939-7395-8_17.

PMID:
29119443
9.

A Lytic Providencia rettgeri Virus of Potential Therapeutic Value Is a Deep-Branching Member of the T5virus Genus.

Oliveira H, Pinto G, Hendrix H, Noben JP, Gawor J, Kropinski AM, Łobocka M, Lavigne R, Azeredo J.

Appl Environ Microbiol. 2017 Nov 16;83(23). pii: e01567-17. doi: 10.1128/AEM.01567-17. Print 2017 Dec 1.

10.

Characterization and genomic analyses of two newly isolated Morganella phages define distant members among Tevenvirinae and Autographivirinae subfamilies.

Oliveira H, Pinto G, Oliveira A, Noben JP, Hendrix H, Lavigne R, Łobocka M, Kropinski AM, Azeredo J.

Sci Rep. 2017 Apr 7;7:46157. doi: 10.1038/srep46157.

11.

Means to Facilitate the Overcoming of Gastric Juice Barrier by a Therapeutic Staphylococcal Bacteriophage A5/80.

Międzybrodzki R, Kłak M, Jończyk-Matysiak E, Bubak B, Wójcik A, Kaszowska M, Weber-Dąbrowska B, Łobocka M, Górski A.

Front Microbiol. 2017 Mar 23;8:467. doi: 10.3389/fmicb.2017.00467. eCollection 2017.

12.

Corrigendum: Bacteriophage Procurement for Therapeutic Purposes.

Weber-Dąbrowska B, Jończyk-Matysiak E, Żaczek M, Łobocka MB, Łusiak-Szelachowska M, Górski A.

Front Microbiol. 2016 Nov 9;7:1813. eCollection 2016.

13.

Isolation of bacteriophages and their application to control Pseudomonas aeruginosa in planktonic and biofilm models.

Kwiatek M, Parasion S, Rutyna P, Mizak L, Gryko R, Niemcewicz M, Olender A, Łobocka M.

Res Microbiol. 2017 Apr;168(3):194-207. doi: 10.1016/j.resmic.2016.10.009. Epub 2016 Nov 4.

PMID:
27818282
14.

Bacteriophage Procurement for Therapeutic Purposes.

Weber-Dąbrowska B, Jończyk-Matysiak E, Żaczek M, Łobocka M, Łusiak-Szelachowska M, Górski A.

Front Microbiol. 2016 Aug 12;7:1177. doi: 10.3389/fmicb.2016.01177. eCollection 2016. Review. Erratum in: Front Microbiol. 2016 Nov 09;7:1813.

15.

[Lysis of bacterial cells in the process of bacteriophage release--canonical and newly discovered mechanisms].

Woźnica WM, Bigos J, Łobocka MB.

Postepy Hig Med Dosw (Online). 2015 Jan 23;69:114-26. Review. Polish.

16.

Phages. Preface.

Łobocka M, Szybalski WT.

Adv Virus Res. 2012;83:xvii-xviii. doi: 10.1016/B978-0-12-394438-2.00013-X. No abstract available.

PMID:
22748816
17.

Genomics of staphylococcal Twort-like phages--potential therapeutics of the post-antibiotic era.

Łobocka M, Hejnowicz MS, Dąbrowski K, Gozdek A, Kosakowski J, Witkowska M, Ulatowska MI, Weber-Dąbrowska B, Kwiatek M, Parasion S, Gawor J, Kosowska H, Głowacka A.

Adv Virus Res. 2012;83:143-216. doi: 10.1016/B978-0-12-394438-2.00005-0. Review.

PMID:
22748811
18.

Advances in Virus Research. Bacteriophages, part A. Preface.

Łobocka M, Szybalski WT.

Adv Virus Res. 2012;82:xiii-xv. doi: 10.1016/B978-0-12-394621-8.00028-5. No abstract available.

PMID:
22420859
19.

Potential of bacteriophages and their lysins in the treatment of MRSA: current status and future perspectives.

Borysowski J, Lobocka M, Międzybrodzki R, Weber-Dabrowska B, Górski A.

BioDrugs. 2011 Dec 1;25(6):347-55. doi: 10.2165/11595610-000000000-00000.

PMID:
22050337
20.

A reliable method for storage of tailed phages.

Golec P, Dąbrowski K, Hejnowicz MS, Gozdek A, Loś JM, Węgrzyn G, Lobocka MB, Loś M.

J Microbiol Methods. 2011 Mar;84(3):486-9. doi: 10.1016/j.mimet.2011.01.007. Epub 2011 Jan 21.

21.

Synthesis of novel aryl(heteroaryl)sulfonyl ureas of possible biological interest.

Saczewski F, Kuchnio A, Samsel M, Łobocka M, Kiedrowska A, Lisewska K, Saczewski J, Gdaniec M, Bednarski PJ.

Molecules. 2010 Feb 26;15(3):1113-26. doi: 10.3390/molecules15031113.

22.

Bacteriophage therapy for the treatment of infections.

Górski A, Miedzybrodzki R, Borysowski J, Weber-Dabrowska B, Lobocka M, Fortuna W, Letkiewicz S, Zimecki M, Filby G.

Curr Opin Investig Drugs. 2009 Aug;10(8):766-74. Review.

PMID:
19649921
23.

Genome of bacteriophage P1.

Łobocka MB, Rose DJ, Plunkett G 3rd, Rusin M, Samojedny A, Lehnherr H, Yarmolinsky MB, Blattner FR.

J Bacteriol. 2004 Nov;186(21):7032-68.

24.
25.

Silencing of genes flanking the P1 plasmid centromere.

Rodionov O, Lobocka M, Yarmolinsky M.

Science. 1999 Jan 22;283(5401):546-9.

26.

P1 plasmid partition: a mutational analysis of ParB.

Lobocka M, Yarmolinsky M.

J Mol Biol. 1996 Jun 14;259(3):366-82.

PMID:
8676375
27.

Characterization of the primary immunity region of the Escherichia coli linear plasmid prophage N15.

Lobocka MB, Svarchevsky AN, Rybchin VN, Yarmolinsky MB.

J Bacteriol. 1996 May;178(10):2902-10.

29.

The pogo transposable element family of Drosophila melanogaster.

Tudor M, Lobocka M, Goodell M, Pettitt J, O'Hare K.

Mol Gen Genet. 1992 Mar;232(1):126-34.

PMID:
1313144
30.

Identification of the dadX gene coding for the predominant isozyme of alanine racemase in Escherichia coli K12.

Wild J, Hennig J, Lobocka M, Walczak W, Kłopotowski T.

Mol Gen Genet. 1985;198(2):315-22.

PMID:
3920477

Supplemental Content

Loading ...
Support Center